Charmcare is a South Korean medical device company founded in 2004 that develops wearable blood pressure monitoring technology. Its products include the H2-BP wristband blood pressure monitor and the H2-ABPM 24-hour ambulatory blood pressure monitoring device used by hospitals and clinics for hypertension diagnosis and treatment-effect evaluation, alongside pulse oximetry devices. The company supplies devices to about 40 countries, holds more than 10 patents in bio-signal technologies, and is developing next-generation ultra-small continuous blood pressure monitoring based on tonometric radial artery measurement. In late 2026 it raised a KRW 1 billion strategic investment from pharmaceutical company Yuhan Corporation to expand its hospital monitoring business and pursue the global digital healthcare market.
1
Round
1
Industry
5
Tags
Oct 19, 2026
Latest raise
Funding activity · 1 round
Oct 19, 2026
KRW 1B
Seed
Led by Yuhan (유한양행)
Article coming soon.
Pricing
Public hubs orient you on the raise. Paid plans unlock live AI adoption signals across your market.
For individuals and small teams getting started with AI buyer intelligence.
$149
/month
Features
For outbound teams and agencies that need more coverage and faster signal cadence.
$249
/month
Features
Act on this raise
Funding is the starting point. VeilStrat shows whether capital is showing up as hiring, tools, and web activity you can sell into.
